Compare IOVA & FIGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | FIGR |
|---|---|---|
| Founded | 2007 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7B | 6.1B |
| IPO Year | 2008 | 2025 |
| Metric | IOVA | FIGR |
|---|---|---|
| Price | $14.11 | $24.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 9 |
| Target Price | $14.40 | ★ $51.56 |
| AVG Volume (30 Days) | ★ 12.5M | 4.0M |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.84 | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $506,865,000.00 |
| Revenue This Year | $56.63 | $109.25 |
| Revenue Next Year | $42.41 | $36.72 |
| P/E Ratio | ★ N/A | $48.10 |
| Revenue Growth | N/A | ★ 48.69 |
| 52 Week Low | $1.76 | $24.10 |
| 52 Week High | $15.37 | $78.00 |
| Indicator | IOVA | FIGR |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 33.38 |
| Support Level | $3.57 | N/A |
| Resistance Level | $15.00 | $34.54 |
| Average True Range (ATR) | 0.92 | 1.72 |
| MACD | -0.17 | -0.18 |
| Stochastic Oscillator | 58.17 | 2.09 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.
Figure Technology Solutions Inc is building the future of capital markets with blockchain technology. proprietary technology powers next-generation lending, trading, and investing activities in areas such as consumer credit and digital assets. Its use of the blockchain ledger allows them to serve their end customers, improve speed and efficiency, and enhance standardization and liquidity. The Company operates as a single operating and reportable segment. The company's geographical operations is within the USA, with the majority of revenue from California.